Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations

NCT07012447 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Early T Acute Lymphoblastic Leukemia
T-Acute Lymphoblastic Leukemia
Mixed Phenotype Acute Leukemia, T/Myeloid, Nos

Interventions

DRUG: Venetoclax
DRUG: Azacitidine
DRUG: Cytarabine

Sponsor

yuejun Liu